Your browser doesn't support javascript.
loading
Correction to: Tolerability and toxicity of trastuzumab or trastuzumab + lapatinib in older patients: a sub­analysis of the ALTTO trial (BIG 2­06; NCCTG (Alliance) N063D).
Pondé, Noam; Agbor-Tarh, Dominique; Dal Lago, Lissandra; Korde, Larissa A; Hilbers, Florentine; Jackisch, Christian; Werner, Olena; Gelber, Richard D; Jatoi, Aminah; Dueck, Amylou C; Moreno-Aspitia, Alvaro; Sotiriou, Christos; de Azambuja, Evandro; Piccart, Martine.
Afiliación
  • Pondé N; AC Camargo Cancer Center, Rua Pires da Mota, São Paulo, 1167, Brazil. noam.ponde@accamargo.org.br.
  • Agbor-Tarh D; Institut Jules Bordet, Brussels, Belgium. noam.ponde@accamargo.org.br.
  • Dal Lago L; Frontier Science Scotland (FSS), Kincraig, UK.
  • Korde LA; Institut Jules Bordet, Brussels, Belgium.
  • Hilbers F; National Cancer Institute, Bethesda, MD, USA.
  • Jackisch C; Breast International Group, Brussels, Belgium.
  • Werner O; Sana Klinikum, Offenbach, Germany.
  • Gelber RD; Novartis, Basel-City, Switzerland.
  • Jatoi A; Dana-Farber Cancer Institute, Boston, USA.
  • Dueck AC; Frontier Science and Technology Research Foundation, Boston, MA, USA.
  • Moreno-Aspitia A; Mayo Clinic, Rochester, MN, USA.
  • Sotiriou C; Mayo Clinic, Scottsdale, AZ, USA.
  • de Azambuja E; Mayo Clinic, Jacksonville, FL, USA.
  • Piccart M; Institut Jules Bordet, Brussels, Belgium.
Breast Cancer Res Treat ; 191(1): 225, 2022 Jan.
Article en En | MEDLINE | ID: mdl-34625860
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Breast Cancer Res Treat Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Breast Cancer Res Treat Año: 2022 Tipo del documento: Article